Author/Authors :
Jae Won Chang، نويسنده , , Micah J. Niphakis، نويسنده , , Kenneth M. Lum، نويسنده , , Armand B. Cognetta III، نويسنده , , Chu Wang، نويسنده , , Megan L. Matthews، نويسنده , , Sherry Niessen، نويسنده , , Matthew W. Buczynski، نويسنده , , Loren H. Parsons، نويسنده , , Benjamin F. Cravatt، نويسنده ,
Abstract :
The endocannabinoids 2-arachidonoyl glycerol (2-AG) and N-arachidonoyl ethanolamine (anandamide) are principally degraded by monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH), respectively. The recent discovery of O-aryl carbamates such as JZL184 as selective MAGL inhibitors has enabled functional investigation of 2-AG signaling pathways in vivo. Nonetheless, JZL184 and other reported MAGL inhibitors still display low-level cross-reactivity with FAAH and peripheral carboxylesterases, which can complicate their use in certain biological studies. Here, we report a distinct class of O-hexafluoroisopropyl (HFIP) carbamates that inhibits MAGL in vitro and in vivo with excellent potency and greatly improved selectivity, including showing no detectable cross-reactivity with FAAH. These findings designate HFIP carbamates as a versatile chemotype for inhibiting MAGL and should encourage the pursuit of other serine hydrolase inhibitors that bear reactive groups resembling the structures of natural substrates.